A Retrospective Study for Multiple Endocrine Neoplasia

• Sponsor: National Taiwan University Hospital (Other)
• Overall Status: Recruiting
• CT.gov ID: NCT05812573
• Collaborator: (none)
• Enrollment: 300
• Location: 1
• Anticipated Duration (Months): 11.1
• Patients Per Site Per Month: 27.1

Study Details

Study Description

Brief Summary

Retrospectively review the clinical characteristics of patients with multiple endocrine neoplasia type I in National Taiwan University Hospital.

Condition or Disease	Intervention/Treatment	Phase
Multiple Endocrine Neoplasia	Other: no intervention

Detailed Description

The investigators will retrospectively review the clinical characteristics of patients with multiple endocrine neoplasia type I in National Taiwan University Hospital.

Study Design

• Study Type: Observational
• Anticipated Enrollment: 300 participants
• Observational Model: Case-Only
• Time Perspective: Retrospective
• Official Title: A Retrospective Study for Multiple Endocrine Neoplasia
• Actual Study Start Date: Mar 14, 2023
• Anticipated Primary Completion Date: Apr 15, 2023
• Anticipated Study Completion Date: Feb 14, 2024

Arms and Interventions

Arm	Intervention/Treatment
multiple endocrine neoplasia patients with multiple endocrine neoplasia	Other: no intervention; No intervention, only observation

Outcome Measures

Primary Outcome Measures

1. Number or endocrine organs involved [2023/2/14-2033/2/14]

   The number of endocrine organs involved in MEN patients

Eligibility Criteria

Criteria

• Ages Eligible for Study: 18 Years to 99 Years
• Sexes Eligible for Study: All
• Accepts Healthy Volunteers: No

Inclusion Criteria:

• Patients with multiple endocrine neoplasia

Exclusion Criteria:

• Patients younger than 18 years old

Contacts and Locations

Locations

	Site	City	State	Country	Postal Code
1	National Taiwan University Hospital	Taipei		Taiwan	100

Sponsors and Collaborators

• National Taiwan University Hospital

Investigators

None specified.

Study Documents (Full-Text)

None provided.

More Information

Publications

None provided.

• Responsible Party: National Taiwan University Hospital
• ClinicalTrials.gov Identifier: NCT05812573
• Other Study ID Numbers: 202302051RINC
• First Posted: Apr 13, 2023
• Last Update Posted: Apr 13, 2023
• Last Verified: Mar 1, 2023

• Studies a U.S. FDA-regulated Drug Product: No
• Studies a U.S. FDA-regulated Device Product: No
• Additional relevant MeSH terms: Neoplasms; Endocrine Gland Neoplasms; Multiple Endocrine Neoplasia

Study Results

No Results Posted as of Apr 13, 2023